GPX4 and neoplasm: Yaqian Du et al. reported a potent ROS production through a multifunctional nanoplatform, simultaneously leading to a depletion of glutathione peroxidase 4 (GPX4) and glutathione (GSH), which in total enhanced the occurrence of tumor ferroptosis and triggered tumor ICD [127].